ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $586,602 | +55.7% | 185,048 | +144.1% | 0.00% | +100.0% |
Q2 2023 | $376,741 | -4.5% | 75,803 | -5.1% | 0.00% | 0.0% |
Q1 2023 | $394,528 | -23.8% | 79,864 | -3.0% | 0.00% | -50.0% |
Q4 2022 | $518,063 | -45.3% | 82,363 | -6.0% | 0.00% | -33.3% |
Q3 2022 | $947,000 | -47.1% | 87,644 | -44.2% | 0.00% | -40.0% |
Q2 2022 | $1,789,000 | +33.4% | 156,961 | +6.6% | 0.01% | +66.7% |
Q1 2022 | $1,341,000 | +2.1% | 147,200 | +67.3% | 0.00% | 0.0% |
Q4 2021 | $1,313,000 | -42.0% | 88,000 | 0.0% | 0.00% | -40.0% |
Q3 2021 | $2,262,000 | -1.4% | 88,000 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $2,295,000 | -10.3% | 88,000 | +21.4% | 0.01% | 0.0% |
Q1 2021 | $2,559,000 | +34.1% | 72,500 | -4.1% | 0.01% | +25.0% |
Q4 2020 | $1,908,000 | -35.1% | 75,600 | -3.0% | 0.00% | -42.9% |
Q3 2020 | $2,938,000 | -11.9% | 77,900 | 0.0% | 0.01% | -22.2% |
Q2 2020 | $3,336,000 | +186.6% | 77,900 | +30.1% | 0.01% | +125.0% |
Q1 2020 | $1,164,000 | -23.0% | 59,900 | +2.9% | 0.00% | 0.0% |
Q4 2019 | $1,512,000 | -4.7% | 58,200 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $1,586,000 | +84.6% | 58,200 | +81.9% | 0.00% | +100.0% |
Q2 2019 | $859,000 | – | 32,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
Navalign, LLC | 74,271 | $623,000 | 0.26% |
PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |